Grand Total EEG Score Can Differentiate Parkinson's Disease From Parkinson-Related Disorders

Abstract

Background: Semi-quantitative electroencephalogram (EEG) analysis is easy to perform and has been used to differentiate dementias, as well as idiopathic and vascular Parkinson's disease. Purpose: To study whether a semi-quantitative EEG analysis can aid in distinguishing idiopathic Parkinson's disease (IPD) from atypical parkinsonian disorders (APDs), and furthermore, whether it can help to distinguish between APDs. Materials and Methods: A comprehensive retrospective review of charts was performed to include patients with parkinsonian disorders who had at least one EEG recording available. A modified grand total EEG (GTE) score evaluating the posterior background activity, and diffuse and focal slow wave activities was used in further analyses. Results: We analyzed data from 76 patients with a final diagnosis of either IPD, probable corticobasal degeneration (CBD), multiple system atrophy (MSA), or progressive supra-nuclear palsy (PSP). IPD patients had the lowest mean GTE score, followed those with CBD or MSA, while PSP patients scored the highest. However, none of these differences were statistically significant. A GTE score of ≤9 distinguished IPD patients from those with APD (p < 0.01) with a sensitivity of 100% and a specificity of 33.3%. Conclusion: The modified GTE score can distinguish patients with IPD from those with CBD, PSP or MSA at a cut-off score of 9 with excellent sensitivity but poor specificity. However, this score is not able to distinguish a particular form of APD from other forms of the disorder.

Applications of machine learning to diagnosis and treatment of neurodegenerative diseases

“…Other methods of monitoring brain activity, such as electroencephalography (EEG), can also benefit from machine learning-driven data analyses. EEG data have been used to distinguish individuals with AD from healthy controls 101 or patients affected by other forms of dementia 102 , as well as to detect functional changes in dopaminergic neurons to diagnose PD 103 . In order to do this, changes in electrical activity frequency over time in different areas of the brain are analysed.…”

Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinsonʼs Disease

“…In PD there is a decrease in EEG fast activities and an increase in slow wave activity in different cortical regions [23,24]. A deteriorated EEG pattern with reduced N400 activation is also present in PD patients with cognitive deficits [25].…”

Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics

“…60 In patients with PD, a decrease in EEG fast activities and an increase in slow wave activity is observed in different neocortical regions. [95][96][97] Abnormal EEG patterns, with reduced N400 activation, are seen in PD patients with cognitive deficits. 98 Reversible beta (β)-bursts in the basal ganglia and other EEG biomarkers of PD can be effectively reduced with L-DOPA treatment.…”